Harel Gadot, CEO of Microbot Medical Inc. (NASDAQ:MBOT), was recently a guest on Benzinga's All Access. Microbot Medical makes the LIBERTY® Endovascular Robotic System, a single-use, fully disposable ...
MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...
Hosted on MSN
FDA clears Microbot’s LIBERTY endovascular robot
The US Food and Drug Administration (FDA) has cleared Microbot’s LIBERTY, a single-use, remotely operated robotic system for peripheral endovascular procedures. Microbot completed the ACCESS-BVI ...
Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA) to bolster its manufacturing capabilities, as well as progress towards the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback